Business UpdateJun 10, 2026, 09:01 AM
Cosmos Health Targets $200M+ Revenue by 2029; FY2025 Revenue $65.3M
AI Summary
Cosmos Health Inc. announced record financial performance and ambitious multi-year guidance, targeting over $200 million in revenue by 2029. The company achieved an all-time high revenue of $65.3 million in FY2025, a 20% increase year-over-year, and reported its strongest-ever Q1 2026 with $17.9 million in revenue, up 31% year-over-year. Strategic initiatives include active U.S. market entry with projected annualized revenue exceeding $20 million, advancing an R&D pipeline, and pursuing a €25 million financing program with the European Investment Bank.
Key Highlights
- Cosmos Health targets over $200M revenue, $44.2M Adjusted EBITDA, and $92.3M stockholders' equity by 2029.
- FY2025 revenue reached a record $65.3M, up 20% year-over-year.
- Q1 2026 revenue was $17.9M, up 31% year-over-year, with strong momentum continuing into Q2.
- Company expects to surpass $90M in revenue for FY2026, representing approximately 38% year-over-year growth.
- U.S. market entry projects annualized revenue exceeding $20M at approximately 75% gross margins within 12-18 months.
- Pursuing a financing program of up to €25M with the European Investment Bank.
- Stockholders' equity increased 7.6% to $19.8M in Q1 2026.
- Identified approximately $20M in non-core assets for monetization to unlock value.
Price Impact
More from COSM